Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146K Sell
30,238
-40,055
-57% -$242K ﹤0.01% 12228
2026
Q1
$433K Sell
70,293
-11,461
-14% -$95.2K ﹤0.01% 10023
2025
Q4
$852K Buy
81,754
+31,919
+64% +$320K ﹤0.01% 7546
2025
Q3
$448K Buy
49,835
+3,684
+8% +$32.3K ﹤0.01% 9211
2025
Q2
$600K Buy
46,151
+1,510
+3% +$22.7K ﹤0.01% 8759
2025
Q1
$1.13M Buy
44,641
+27,620
+162% +$821K ﹤0.01% 6941
2024
Q4
$585K Buy
17,021
+12,072
+244% +$544K ﹤0.01% 8283
2024
Q3
$245K Sell
4,949
-4,044
-45% -$207K ﹤0.01% 10067
2024
Q2
$541K Sell
8,993
-1,075
-11% -$61.4K ﹤0.01% 8080
2024
Q1
$519K Sell
10,068
-5,747
-36% -$282K ﹤0.01% 8411
2023
Q4
$638K Sell
15,815
-3,943
-20% -$116K ﹤0.01% 8078
2023
Q3
$551K Sell
19,758
-34,708
-64% -$1.03M ﹤0.01% 8002
2023
Q2
$1.57M Buy
54,466
+44,261
+434% +$985K ﹤0.01% 5660
2023
Q1
$170K Buy
+10,205
New +$144K ﹤0.01% 10793
2022
Q2
Sell
-10,869
Closed -$135K 13811
2022
Q1
$135K Buy
+10,869
New +$130K ﹤0.01% 11656

Other funds holding RXST

Jeff Yass's RXST Position: Q2 2026 in Review

Jeff Yass reduced its RxSight (RXST) stake by 57% in Q2 2026, selling an estimated $242K and leaving 30,238 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #12228.

Jeff Yass first reported a position in RXST in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.57M in Q2 2023. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Jeff Yass held 30,238 shares of RxSight worth $146K as of Q2 2026.
  • Jeff Yass sold 40,055 RxSight shares in Q2 2026, an estimated $242K.
  • RxSight made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12228 holding.
  • Jeff Yass first reported a position in RxSight in Q1 2022 and has held it in 15 quarters since.
  • Jeff Yass's RxSight position peaked at $1.57M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.